MARKET

SIGY

SIGY

Sigyn Therapeutics Inc
OTCMQB
0.022
-0.028
-56.00%
Closed 15:03 03/06 EST
OPEN
0.040
PREV CLOSE
0.050
HIGH
0.040
LOW
0.022
VOLUME
153.74K
TURNOVER
3.65K
52 WEEK HIGH
19.20
52 WEEK LOW
0.022
MARKET CAP
35.32K
P/E (TTM)
-0.0109
1D
5D
1M
3M
1Y
5Y
1D
Sigyn Therapeutics Secures Funding via New Convertible Notes
TipRanks · 02/20 19:57
Signet Jewelers Limited Q3 Profit Increases, Beats Estimates
NASDAQ · 12/02/2025 12:23
Weekly Report: what happened at SIGY last week (0908-0912)?
Weekly Report · 09/15/2025 11:41
Weekly Report: what happened at SIGY last week (0901-0905)?
Weekly Report · 09/08/2025 11:43
Sigyn Therapeutics Inc. Reports No Revenue and $1.45 Million Net Loss for Q2 2025
Reuters · 09/05/2025 19:49
Signet Jewelers Posts Narrower Loss In Q2; Raises FY26 Guidance
NASDAQ · 09/02/2025 11:19
Weekly Report: what happened at SIGY last week (0825-0829)?
Weekly Report · 09/01/2025 11:37
Weekly Report: what happened at SIGY last week (0818-0822)?
Weekly Report · 08/25/2025 11:51
More
About SIGY
Sigyn Therapeutics, Inc. develops medical devices to treat cancer and infectious disease disorders. The Company's lead therapeutic candidate, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders. Candidate treatment indications include endotoxemia and inflammation in end-stage renal disease (dialysis) patients, sepsis (a cause of hospital deaths), community-acquired pneumonia (a cause of death among infectious diseases), and emerging pandemic threats. Sigyn Therapy is a single-use disposable device that is deployable on the global infrastructure of hemodialysis and continuous renal replacement therapy machines. Its development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the tumor site delivery of chemotherapy, and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis. Its ImmunePrep platform enhances the performance of immunotherapeutic antibodies.

Webull offers Sigyn Therapeutics Inc stock information, including OTCMQB: SIGY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIGY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SIGY stock methods without spending real money on the virtual paper trading platform.